RIDAURA auranofin 3mg capsules (Canada)
Section 19A approved medicine
RIDAURA auranofin 3mg capsules (Canada)
Section 19A approval holder
Boucher & Muir Pty Ltd T/A Advanz Pharma ABN 58 000 140 474
Phone
02 9431 6333
Approved until
Status
Current
Medicines in short supply/unavailable
RIDAURA auranofin 3mg tablet bottle - ARTG 13000
Indication(s)
Adjunctive treatment of active classical or definite rheumatoid arthritis in adults who have an insufficient therapeutic response to, or are intolerant of, an adequate trial of a baseline therapeutic program, including among other measures, full doses of one or more non-steroidal anti-inflammatory drugs. RIDAURA is not indicated in non-rheumatoid arthropathies such as osteoarthrosis. RIDAURA should be added to a comprehensive baseline therapeutic program.
Additional information
Images
